Brookfield Short Interest Hits a Year-High as the Stock Quietly Grinds Up

BN has rarely attracted much short-seller attention, but the past month has brought the biggest build in borrowed shares in at least a year, arriving just as the stock trades at its highest levels in months.

Short interest has climbed 48% since late September to 13.8 million shares, or 0.6% of the free float. In absolute terms that remains a thin position against a CAD 85 billion company. But the pace of the build is the story: two separate step-changes lifted the short book from roughly 9.4 million shares at end-September to where it is today, with the most recent increment locked in from October 20 onward. At the same time, BN itself gained 1.8% on the week, meaning shorts added exposure into price strength. Days-to-cover is 4.3, so unwinding even this modest position would take the best part of a week at normal volumes.

The lending market tells a very different story from the positioning data. Borrow availability is effectively unlimited: the 52-week high on utilization reached just 6.75%, and today it is under 1%, with over 1.3 billion shares available in the lending pool. Borrowing costs have eased too, falling 12% on the week to 0.57% annualized, one of the lowest readings of the past six weeks. None of that points to a crowded short or any squeeze risk. The borrow market is loose; only the absolute share count has moved meaningfully.

On the Street, Brookfield is priced for patient, long-duration capital. The P/E sits at 36.4x on fiscal 2025 earnings, with EV/EBITDA at 36.5x, both of which have drifted fractionally lower over the past month. The price-to-book of 1.9x has nudged up over the same period. Factor scores reflect that positioning: dividend quality ranks in the 91st percentile and earnings yield ranks in the 88th, two signals that appeal to income-oriented holders. The ORTEX short score of 28.7, low on a 0-to-100 scale, is consistent with the rest of the picture: very little short-side conviction in the name.

Close peer BAM gained 1.8% on the week, almost identical to BN. ARES ran harder, up 5.1%. ONEX added 2.1%. KKR gained 3%. BN's week was therefore broadly in line with the median of its closest peers, neither leading the alternative-asset manager group nor lagging it.

The institutional register anchors the stock firmly. Partners Value Investments holds 8% of shares, Capital Research 4.3%, and Pershing Square Capital Management holds 2.6%, having added nearly 4.9 million shares in the period ending June 30. Several Canadian managers, including BMO Asset Management and RBC Global Asset Management, also added modestly. On the insider side, the most recent material activity was an August 19 exercise-and-sale by CFO Justin Beber totaling roughly USD 8 million in net proceeds. That is routine for a stock compensation cycle at this level, not a signal on the stock's direction.

Earnings are confirmed for November 12. With short interest at its highest in at least a year, the key question for that date is whether the recent borrowing activity reflects a genuine thesis against Brookfield's fee-bearing capital growth, or simply a routine hedge against the complex multi-entity structure of the Brookfield family.